Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.145
+0.055 (5.05%)
Feb 6, 2026, 3:01 PM EST - Market open
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $70.36 million as of February 6, 2026. Its market cap has decreased by -89.41% in one year.
Market Cap
70.36M
Enterprise Value
-112.50M
1-Year Change
-89.41%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $70.36M, a decrease of -90.46%. That is a compound annual growth rate of -33.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 66.98M | -10.66% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 72.11M |
| XBiotech | 71.65M |
| Pelthos Therapeutics | 70.99M |
| iBio, Inc. | 69.96M |
| Immunic | 69.77M |
| Alterity Therapeutics | 68.38M |
| MindWalk Holdings | 67.24M |
| Adicet Bio | 66.50M |